DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Peregrine Pharmaceuticals (NASDAQ: PPHM)

1.39 -0.04 (-2.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PPHM $1.39 -2.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.42
Previous Close $1.43
Daily Range $1.39 - $1.44
52-Week Range $1.19 - $2.00
Market Cap $261.8M
P/E Ratio -4.93
Dividend (Yield) $0.00 (0.0%)
Volume 789,417
Average Daily Volume 1,412,814
Current FY EPS -$0.30

Sector

Healthcare

Industry

Drug Makers

Peregrine Pharmaceuticals (PPHM) Description

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. Website: http://www.peregrineinc.com/

News & Commentary Rss Feed

5 Promising Biotech Stocks Under $10

Don't let their share price fool you. These five biotech stocks have the potential to double your money many times over if their product pipelines meet expectations.

Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2015 Annual Me

Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2015 Annual Meeting

Skip Peregrine Pharmaceuticals For 2015

Peregrine Pharmaceuticals' (PPHM) CEO Steve King on Q3 2015 Results - Earnings Call Transcript

Peregrine Pharmaceuticals (PPHM) Stock Gains on Revenue Beat

Peregrine Pharmaceuticals (PPHM) Q3 2015 Results - Earnings Call Webcast

Earnings Reaction History: Peregrine Pharmaceuticals Corporation, 42.9% Follow-Through Indicator, 6.

Earnings Reaction History: Peregrine Pharmaceuticals Corporation, 42.9% Follow-Through Indicator, 6.1% Sensitive

Peregrine Pharmaceuticals (PPHM) Highlighted As Weak On High Volume

Why Peregrine Pharmaceuticals Tacked on 10% in February

Peregrine Pharmaceuticals ushers in a double-digit percentage gain in February after releasing new preclinical trial data. Here's what investors need to know.

Wall Street's Current Play: 'Immunotherapy Of Cancer'

See More PPHM News...

PPHM's Top Competitors

PPHM $1.39 (-2.80%)
Current stock: PPHM
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB